Literature DB >> 25345101

Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment.

Line Borgwardt, Allan Meldgaard Lund, Christine I Dali.   

Abstract

Alpha-mannosidosis (OMIM 248500) is a rare, autosomal recessive, multisystemic, progressive lysosomal storage disorder caused by a deficiency of alpha-mannosidase. It has been described in humans, cattle, domestic cats, mice and guinea pigs. In humans, alpha-mannosidosis results in progressive facial- and skeletal abnormalities, motor impairment, hearing impairment, intellectual disability, recurrent infections and immune deficiency. This review provides detailed information regarding the variability of manifestations and a description of current treatment and treatment under investigation for alpha-mannosidosis. The pathology, genetics and clinical pictures, including impairments in the activity of daily living are discussed.

Entities:  

Mesh:

Year:  2014        PMID: 25345101

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  13 in total

1.  Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.

Authors:  Arun Babu Kumar; Xinying Hong; Fan Yi; Tim Wood; Michael H Gelb
Journal:  Mol Genet Metab       Date:  2019-06-10       Impact factor: 4.797

2.  Early clinical signs in lysosomal diseases.

Authors:  Camelia Alkhzouz; Diana Miclea; Simona Bucerzan; Cecilia Lazea; Ioana Nascu; Paula Grigorescu Sido
Journal:  Med Pharm Rep       Date:  2021-08-10

Review 3.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

4.  Differentially methylated obligatory epialleles modulate context-dependent LAM gene expression in the honeybee Apis mellifera.

Authors:  Laura Wedd; Robert Kucharski; Ryszard Maleszka
Journal:  Epigenetics       Date:  2015-10-27       Impact factor: 4.528

5.  Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.

Authors:  Line Borgwardt; Hilde Monica Frostad Riise Stensland; Klaus Juul Olsen; Flemming Wibrand; Helle Bagterp Klenow; Michael Beck; Yasmina Amraoui; Laila Arash; Jens Fogh; Øivind Nilssen; Christine I Dali; Allan Meldgaard Lund
Journal:  Orphanet J Rare Dis       Date:  2015-06-06       Impact factor: 4.123

6.  Developmental and loco-like effects of a swainsonine-induced inhibition of α-mannosidase in the honey bee, Apis mellifera.

Authors:  Laura Wedd; Regan Ashby; Sylvain Foret; Ryszard Maleszka
Journal:  PeerJ       Date:  2017-03-16       Impact factor: 2.984

7.  Retinal and optic nerve degeneration in α-mannosidosis.

Authors:  Juliane Matlach; Thea Zindel; Yasmina Amraoui; Laila Arash-Kaps; Julia B Hennermann; Susanne Pitz
Journal:  Orphanet J Rare Dis       Date:  2018-06-01       Impact factor: 4.123

8.  Frontline Science: Employing enzymatic treatment options for management of ocular biofilm-based infections.

Authors:  Abirami Kugadas; Jennifer Geddes-McAlister; Emilia Guy; Antonio DiGiandomenico; David B Sykes; Michael K Mansour; Rossen Mirchev; Mihaela Gadjeva
Journal:  J Leukoc Biol       Date:  2019-01-28       Impact factor: 4.962

Review 9.  The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases.

Authors:  Brianna M Naumchik; Ashish Gupta; Heather Flanagan-Steet; Richard A Steet; Sara S Cathey; Paul J Orchard; Troy C Lund
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

10.  Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Authors:  Allan M Lund; Line Borgwardt; Federica Cattaneo; Diego Ardigò; Silvia Geraci; Mercedes Gil-Campos; Linda De Meirleir; Cécile Laroche; Philippe Dolhem; Duncan Cole; Anna Tylki-Szymanska; Monica Lopez-Rodriguez; Encarna Guillén-Navarro; Christine I Dali; Bénédicte Héron; Jens Fogh; Nicole Muschol; Dawn Phillips; J M Hannerieke Van den Hout; Simon A Jones; Yasmina Amraoui; Paul Harmatz; Nathalie Guffon
Journal:  J Inherit Metab Dis       Date:  2018-05-03       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.